(NASDAQ:COST), 240 JOBS CREATED, THOUSANDS OF UNIQUE ITEMS TAILORED TO BUSINESS NEEDS EAST GWILLIMBURY, Ontario, Dec. 06, 2025 (GLOBE NEWSWIRE) — Costco Wholesale opened its tenth Canadian Business Centre today, located at 18182 Yonge Street, south of York Regional Rd 19. The 137,000 square-foot facility is a conversion of the original Costco Newmarket which recently […]
(NasdaqGM:IRON), Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response was seen independent of concomitant JAK inhibitor therapy use WATERTOWN, Mass., Dec. 06, 2025 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering
(NasdaqGM:BCAX), Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety profile comparable to 1500mg QW dose, further derisking pivotal FORTIFI-HN01 study interim analysis Totality of data demonstrates that greater TGF-B inhibition, observed at 1500mg of ficerafusp alfa, drives deeper tumor responses that translate to more durable outcomes for patients
(NASDAQ:BEAM), Updated Data from 31 Adult and Adolescent SCD Patients Treated with risto-cel (Formerly BEAM-101) Show Mean Hemoglobin F (HbF) Induction of >60%, Hemoglobin S (HbS) Reduction to <40%, and Resolution of Anemia Durable for up to 20 Months Patients Required a Median of One Cell Collection Cycle and Experienced Rapid Neutrophil and Platelet Engraftment
(TSX:APS),(OTC US:APTOF),(Other OTC:APTOF), TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed AML patients with diverse mutations Safety continues to be a notable hallmark of TUS-based therapies 100% response rate (CR/CRh) at the two higher dose levels (80 and 120 mg TUS dose) CR/CRh observed in FLT3 wildtype subjects,
~As Jamaica Moves Forward, Visitors Return to Play a Powerful Role in Supporting LocalCommunities and the Island's Vibrant Recovery~ Sandals Resorts International (SRI), the Caribbean's leading all-inclusive resort company, reopened five of their Jamaica properties today, marking a major step forward for tourism on the island. https://mma.prnewswire.com/media/2839885/SRI_logo_Logo.jpg The returning resorts include Sandals Dunn's River, Sandals
Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting GlobeNewswire December 06, 2025 Updated Data from 31 Adult and Adolescent SCD Patients Treated with risto-cel (Formerly BEAM-101) Show Mean Hemoglobin F (HbF) Induction
Aptose's Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations GlobeNewswire December 06, 2025 TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed AML patients with diverse mutations Safety continues to be a notable hallmark of TUS-based
Canada's Tenth Costco Business Centre is now open in East Gwillimbury GlobeNewswire December 06, 2025 240 JOBS CREATED, THOUSANDS OF UNIQUE ITEMS TAILORED TO BUSINESS NEEDS EAST GWILLIMBURY, Ontario, Dec. 06, 2025 (GLOBE NEWSWIRE) — Costco Wholesale opened its tenth Canadian Business Centre today, located at 18182 Yonge Street, south of York Regional Rd 19.
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting GlobeNewswire December 06, 2025 Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response was seen independent of concomitant JAK inhibitor